ERSTE Stock Biotec R01 T
AT0000746755
ERSTE Stock Biotec R01 T/ AT0000746755 /
| NAV2024-04-17 |
Chg.-2.7800 |
Type of yield |
Investment Focus |
Investment company |
| 453.3400EUR |
-0.61% |
reinvestment |
Equity
Sector Biotechnology
|
Erste AM ▶ |
Investment goal
The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Country: |
United States of America |
| Branch: |
Sector Biotechnology |
| Benchmark: |
- |
| Business year start: |
03-15 |
| Last Distribution: |
2022-06-13 |
| Depository bank: |
Erste Group Bank AG |
| Fund domicile: |
Austria |
| Distribution permission: |
Austria, Germany |
| Fund manager: |
Harald Kober, Tamas Menyhart |
| Fund volume: |
217.05 mill.
EUR
|
| Launch date: |
2000-04-17 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
4.00% |
| Max. Administration Fee: |
1.80% |
| Minimum investment: |
0.00 EUR |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Erste AM |
| Address: |
Am Belvedere 1, 1100, Wien |
| Country: |
Austria |
| Internet: |
www.erste-am.at
|
Countries
| United States of America |
|
81.14% |
| United Kingdom |
|
7.94% |
| Netherlands |
|
2.75% |
| Cash |
|
2.31% |
| Bermuda |
|
1.07% |
| Denmark |
|
1.01% |
| Canada |
|
1.00% |
| China |
|
0.95% |
| Ireland |
|
0.76% |
| Virgin Islands (British) |
|
0.49% |
| Cayman Islands |
|
0.32% |
| Belgium |
|
0.19% |
| Others |
|
0.07% |
Branches
| Pharma/Biotechnology |
|
93.00% |
| Healthcare services |
|
4.69% |
| Cash |
|
2.31% |
